Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert E. Waltermire Insider Profile
11 Followers
Robert E. Waltermire, SVP, Chief Pharma Dev at Madrigal Pharmaceuticals, holds 5.50K shares in Madrigal Pharmaceuticals (Ticker: MDGL). Most recently, Robert E. Waltermire Sold $1,900 shares of Madrigal Pharmaceuticals on Jun 18, 2024 for an estimated value of 532.00K.
Robert E. Waltermire Madrigal Pharmaceuticals (MDGL)SVP, Chief Pharma Dev
Madrigal Pharmaceuticals (MDGL)
SVP, Chief Pharma Dev
Ranked #88,644 out of 99,635 Corporate Insiders
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-31.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert E. Waltermire's holdings
Insider Roles
SVP, Chief Pharma Dev
Roles that Robert E. Waltermire holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 02, 2023 - Mar 02, 2024
Return:+7.70%
The most profitable trade made by Robert E. Waltermire
Robert E. Waltermire's Trading History
List of latest transactions for each holding click on a transaction to see Robert E. Waltermire's performance on stock
You May Also Like
Robert E. Waltermire insider profile FAQ
What is the percentage of profitable transactions made by Robert E. Waltermire?
The percentage of profitable transactions made by Robert E. Waltermire is 17%.
What is the average return per transaction made by Robert E. Waltermire?
The average return per transaction made by Robert E. Waltermire is -31.80%.
What stocks does Robert E. Waltermire hold?
Robert E. Waltermire holds: MDGL stocks.
What was Robert E. Waltermire’s latest transaction?
Robert E. Waltermire latest transaction was an Informative Sell of $532.00K.
What was Robert E. Waltermire's most profitable transaction?
Robert E. Waltermire’s most profitable transaction was an Informative Sell of MDGL stock on March 2, 2023. The return on the trade was 7.70%.
What is Robert E. Waltermire's role in Madrigal Pharmaceuticals?
Robert E. Waltermire's role in Madrigal Pharmaceuticals is SVP, Chief Pharma Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.